Introduction
The role of values in scientific inquiry has long been debated. Some scientists support the value-free method, while others argue that values are necessary for scientific investigation (Calina et al.). As part of the discussion on the COVID-19 pandemic, this paper argues that science, ethics, and culture are interconnected. In other words, moral and value judgments shaped the global scientific reaction to COVID-19, from interviewing research questions and creating hypotheses to designing clinical trials, communicating findings, and applying scientific knowledge. Specifically, the paper explains that the Greatest Struggle highlighted science’s ideals, casting doubt on its value-free nature. As part of the argument, this paper contends that morals are crucial to scientific integrity, social relevance, and legitimacy, not invaders. Moreover, research concludes that pluralistic values and ethical epistemological norms are the best ways to ensure responsible, objective, and community-focused scientific initiatives.
Explaining the paper’s Contribution to the Debate
This dispute about the place of values in research pairing those of Douglas and Elliot had called for robust support of the conclusion favoring the value-laden view of science. On that note, this paper could pinpoint the ideal of value-free science championed by notable thinkers like W. E. B. Du Bois and Gregor Betz do not confront the diverse realities of the science of how academic inquiries are carried out in as much as complex situations that involve uncertainties of great magnitude (Douglas). The recent case of COVID-19 highlights the stark and meaningful deficiencies in the notion of being unbiased and value-free as engaged in science.
Arguing for the Contribution
The rapid emergence of the global challenge caused by the COVID-19 pandemic showcases quite clearly that whatever sets of ethical, social, and cultural values were in place, they infiltrated and molded the entire form and shape of scientific research work from issue to issue (Duxbury 390). With the deadly pandemic assuming an unyielding and universally reaching character, within the blink of an eye, it became the scientific priority to devise potent therapeutics and vaccines as quickly as possible for combating the novel viral infection. However, compared to other General Assembly meetings, this monolithic venture was fraught with moral and ethical dilemmas that were highly pertinent to the decision-making process. During selecting and accentuating the potential COVID-19 interventions, the value was irrefutably a game changer in the strategized plan (Calina et al.). Under such criteria, limited resources, and the devastating effects of diseases on public health and safety, researchers and scientists had to bias their choices. Instead, researchers select the most relevant therapeutic approaches from the myriad possibilities in the desperately unleashing of time and the awakened sufferings. These choices were made based on empirical data and significant ethical issues such as risk, justice, and affordability of the therapies and medication (Calina et al.).
However, another group of researchers purposefully privileged the repurposing approach, given that faster entry into the clinic became a more realistic goal than the more protracted process of discovering new drugs and drug candidates (Douglas). Concomitantly, the calculus of choice involved a trade-off between more significant risks of adverse effects when repurposing drugs designed to combat other diseases and more probable risks that are not unsafe but have more extended periods than de novo drug development pipelines (Douglas). Behind the informed decisions about what to do first is the fundamental belief about the most ethical part between the exponential crisis growth’s emergency reduction and the longer-term harm-reduction approaches, with a slight delay but with convenience. In addition, what arose as a result of the collective process of the design and implementation of clinical trials for COVID-19 therapeutics was the influence of complex interactions among epistemic and non-epistemic values on almost the whole study (Lie et al.). On the one hand, scientists had to adhere accurately to the high teaching methodological standards and golden rules of statistics so that other scientists could consider their findings as actual and corroborated. At the same time, however, they decided on a dangerous line, on which they embarked on rapid testing of the clinical possibilities that can save lives. Another aim was to fulfill the ethical obligations to protect human subjects and publicly valuable evidence (Lie et al.).
These differences in imperative values were demonstrated in debates about the appropriate pragmatic design of the experiment, which was loaded with great ethical significance. Experiments covered the scope of placebo controls, the danger-to-benefit ratio of human challenge trials, and the establishment of study cohorts according to the principles of equity and distribution (Dawson et al.). In the meantime, such value problems as how to interpret, communicate, or translate scientifically knowledgeable COVID-19 research in public health policies or guidelines become an inextricable part of the scope of this problem (Duxbury 395). The number of human lives lost and the danger of other illnesses and medical problems make this communication a complicated process for scientific experts and institutions. Specifically, it implies that they have to find ways of conveying qualitative data with huge uncertainty and limitations in a way that works for public health policymakers without creating unnecessary panic. At the same time, it is crucial to reveal the limitations and nuances of their work so as not to confuse the public (Duxbury 398). Understanding the complications and complexity of genetically modified food involved using sophisticated social sense, ethics, and politics to handle the public’s reaction. Minimizing uncertainties may corrupt public confidence and lead to a situation in which the leaders fail to do what is necessary to make people follow preventive rules. On the contrary, too many risks in early or first-stage results could be used only to support inaction, misleading or finally empowering the ideological group that continues to deny the scientific conclusion. Ultimately, it was shown to be a highly delicate balancing act that required epistemic rigor about the validity of empirical evidence and other non-epistemic values. These include getting people’s trust, helping promote public welfare, and respecting stakeholders’ autonomy (Douglas).
If we want to understand it correctly, we must realize that during the COVID-19 pandemic, the international scene highlighted the tightly knit connection between scientific research and ethical values that goes beyond the value-free ideal, which did not address its fundamentals (Elliott). In fact, from the type of questions being put forward based on ethical and social considerations to the design of efficacy trials and the way the advisories are communicated, the global scientific response was pervaded by moral and value judgments. This could be addressed and was necessary to support the ethicality, the public’s accountability, and the application’s effectiveness. Moreover, the non-objective basis of an ethos is necessary for the scientific community to reasonably derive from facts through sound moral thought to address an existential crisis (Elliott). This is as opposed to the majestic ideal of only objective thinking, where the society scientific community’s primary objective is to ignore the ethical component from which most scientific findings are derived.
Considering an Objection.
Opponents may agree that values played a critical function in the pandemic response. However, they may like to downplay it as an extraordinary interruption rather than solely refer to it as a refuting evidence of the normative aspirations of the ideal of the “value-free science” (Douglas). Some objectors may argue that the pandemic is a unique case study of a closer timeline and greater uncertainty levels and thus cannot be taken as a typical representation of scientific activities that thrive on measured circumstances. When instantaneous crises do not occur in routine research settings, coolheaded rationality still represents the best way to manage them and insulate science against potentially diversionary or pernicious ethical influences.
Defending the Objection
While this paper grants that the COVID-19 pandemic was a very extreme situation that not only increased but also eventually unleashed the readiness of all those values that powered science’s rapid progress, it also argues that the pandemic did not necessarily bring the values that were the key catalysts (Douglas). Again, while the pandemic has reiterated how science has always been tied in various invisible but consequential threads to social and cultural aspects of life, perhaps the phenomenon is subtler and more implicit in more traditional settings. Posit that any contention of uncontaminated value-free pursuance of scientific investigation will imply philosophical visionary deficiency since ignorance of these inseparable ethical dimensions as a chain of causation would undoubtedly influence the end research result. In his profound, precise analysis, Kevin Elliot reveals that values play a significant role in forming hypotheses and selecting methodologies. This is mainly true if the investigators decide what is scientifically worthy of investigation in the first place (Elliott). However, it is not that these initial choices, which define what kind of program one’s research is aimed at and what its boundaries will be, are built on empirical findings exclusively. Their implicitness stems from the fact that scientists are already guided by their belief frameworks, life experiences, institutional settings, and social standpoints, which, by design, bear traces of enculturation. They are also shaped by wealth distribution, social positioning, and different forms of social control. Statements that do not recognize value appeals fail to address the fact that subjective judgments remain unaltered despite the underlying bias through the rigors of scientific studies.
Besides, research methods of even the highest technical and empirical nature, such as data collection and statistical analysis, do not possess the hermetic package to prevent the infusion of ethical factors (Douglas). According to Douglas, assessing inductive risks of wrongly accepting or rejecting hypotheses based on sample-only initiated investigations is the central shape of researchers’ perception of those risks and the consequences of being wrong or making a decision based on insufficient information. In this regard, this risk analysis is a moral exercise to choose between two opposite evils. The problems could be the potential health and safety risks to humans, devastation to natural resources, squandering away valuable research efforts, or damage to the global scientific community’s image. Every occasion of p-value cut-off or power determination entails the poorest judgments regarding the acceptability of induction rather than remaining as an objective application of purely mathematical rules. Ethical facets that appear even at the tiny marginal methodological decisions epitomize that ethical considerations in science cannot be regarded as regrettable intrusions spoiling the objectivity but as something that is part and parcel of the integrity and authenticity of the conduct of research (Elliott). Through discussions that openly reflect upon the ethical frameworks and value contexts that are pertinent to their area of study, researchers can admit the process of publicly and transparently wrestling with these moral issues, thus reinforcing trust, accomplishing social relevance, and encouraging interrogation of the assumptions that could in normal situation go unquestioned. Nevertheless, the choice that there would always be an unconscious bias implying community separatism and increasing the growing public distrust of authority will be lessened when society views the scientists as intellectuals or experts without changing their ideas about the immaterial and inexpressible ideal values.
In conclusion, the COVID-19 pandemic showed that morals, society, and ethics influence scientists’ actions. From start to finish, the international scientific response has shown that ethical responsibility and empirical objectivity are not opposing components that we should choose between but aspects that should be dwelled in without hesitation and gently relaxed through constant reflection. Without standards, ethics, and values for scientific truth-finding, self-deception would rule. This strategy hides moral interpretation’s essential significance in science. The objective is to accept and incorporate profoundly held beliefs into an epistemological framework that enforces autonomy, recognizes knowledge gaps, and improves scientific discoveries’ credibility to maintain a healthy society (Elliott). Ethical scientific management improves rigor and integrity, contrary to the belief that subjective scientific space affects objectivity. Attributing research embedding to social autonomy, recognizing our subjective uniqueness perspectival constraints, and emphasizing procedural responsiveness to moral relevance balances empirical correctness and ethical integrity (Douglas). Science’s “misty” detachment from ethical choices does not matter in fighting lies and promoting humanitarianism. Instead, science’s epistemic practice requires value pluralism knowledge. COVID-19 created the most acute sense of fast change.
Works Cited
Calina, Daniela, et al. “Towards Effective COVID-19 Vaccines: Updates, Perspectives and Challenges.” Life Sciences, vol. 265, 2020, p. 118823. https://doi.org/10.1016/j.lfs.2020.118823.
Douglas, Heather. Science, Policy, and the Value-Free Ideal. University of Pittsburgh Press, 2009.
Duxbury, Tom. “Scientific Uncertainty and Social Responsibility: The COVID-19 Curveball.” Health Risk & Society, vol. 22, no. 7–8, 2020, pp. 389–403. https://doi.org/10.1080/13698575.2020.1857905./
Elliott, Kevin C. A Tapestry of Values: An Introduction to Values in Science. Oxford University Press, 2017.
Lie, Reidar K., et al. “Core Values, Positions and Strategies – COVID-19 Vaccine Ethics.” F1000Research, vol. 9, 2020, p. 1124.
write